Inogen Inc logo

INGN - Inogen Inc Share Price

$61 -1.8  -2.9%

Last Trade - 20/04/21

Mid Cap
Market Cap £999.5m
Enterprise Value £834.2m
Revenue £220.6m
Position in Universe 2530th / 6849
Unlock INGN Revenue
Relative Strength (%)
1m +16.2%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -5.77%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
159 202.8 249.4 358.1 361.9 308.5 330.9 362.8 +14.2%
+91.4 +73.9 +34.2 +76.4 -57.7
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, InogenInc revenues decreased 15% to $308.5M. Net loss totaled$5.8M vs. income of $21M. Revenues reflect Sales revenuedecrease of 18% to $280.2M. Net loss reflects Research andDevelopment - Balancing val increase of 58% to $13.1M(expense), Interest Income decrease of 81% to $909K(income), General and administ increase of 11% to $35.2M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


INGN Revenue Unlock INGN Revenue

Net Income

INGN Net Income Unlock INGN Revenue

Normalised EPS

INGN Normalised EPS Unlock INGN Revenue

PE Ratio Range

INGN PE Ratio Range Unlock INGN Revenue

Dividend Yield Range

INGN Dividend Yield Range Unlock INGN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
INGN EPS Forecasts Unlock INGN Revenue
Profile Summary

Inogen, Inc. is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company's Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device. Its three portable product offerings, the Inogen One G4, Inogen One G3 and Inogen One G2, at approximately 2.8, 4.8 and 7.0 pounds with a single battery, respectively. Its Inogen One G4, Inogen One G3 and Inogen One G2 are sub-3, sub-5 and sub-10 pound portable oxygen concentrators, respectively. All of its Inogen One systems are equipped with Intelligent Delivery Technology. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory oxygen patient market and serves as a backup to its Inogen One system for ambulatory patients on its rental service.

Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated November 27, 2001
Public Since February 14, 2014
No. of Shareholders: 27
No. of Employees: 938
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nasdaq Composite , S&P 600 Small Cap , S&P Composite 1500 ,
Exchange NASDAQ Global Select Market
Shares in Issue 22,248,694
Free Float (0.0%)
Eligible for
INGN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for INGN
Upcoming Events for INGN
Monday 10th May, 2021
Inogen Inc Annual Shareholders Meeting
Tuesday 11th May, 2021 Estimate
Inogen Inc Annual Shareholders Meeting
Frequently Asked Questions for Inogen Inc
What is the Inogen Inc share price?

As of 20/04/21, shares in Inogen Inc are trading at $61, giving the company a market capitalisation of £999.5m. This share price information is delayed by 15 minutes.

How has the Inogen Inc share price performed this year?

Shares in Inogen Inc are currently trading at $61 and the price has moved by 27.42% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Inogen Inc price has moved by -14.05% over the past year.

What are the analyst and broker recommendations for Inogen Inc?

Of the analysts with advisory recommendations for Inogen Inc, there are there are currently 0 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Inogen Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Inogen Inc next release its financial results?

Inogen Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Inogen Inc dividend yield?

Inogen Inc does not currently pay a dividend.

Does Inogen Inc pay a dividend?

Inogen Inc does not currently pay a dividend.

When does Inogen Inc next pay dividends?

Inogen Inc does not currently pay a dividend.

How do I buy Inogen Inc shares?

To buy shares in Inogen Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Inogen Inc?

Shares in Inogen Inc are currently trading at $61, giving the company a market capitalisation of £999.5m.

Where are Inogen Inc shares listed? Where are Inogen Inc shares listed?

Here are the trading details for Inogen Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: INGN
What kind of share is Inogen Inc?

Based on an overall assessment of its quality, value and momentum, Inogen Inc is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Inogen Inc share price forecast 2021?

Shares in Inogen Inc are currently priced at $61. At that level they are trading at 6.61% premium to the analyst consensus target price of 0.00.

Analysts covering Inogen Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.708 for the next financial year.

How can I tell whether the Inogen Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Inogen Inc. Over the past six months, the relative strength of its shares against the market has been 86.92%. At the current price of $61, shares in Inogen Inc are trading at 58.7% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Inogen Inc PE Ratio?

We were not able to find PE ratio data for Inogen Inc.

Who are the key directors of Inogen Inc?

Inogen Inc's management team is headed by:

Heath Lukatch - NEC
Raymond Huggenberger - IND
Alison Bauerlein - CFD
Brenton Taylor - CFD
Benjamin Anderson-Ray - IND
Loren McFarland - IND
R. Scott Greer - IND
Bart Sanford - EVP
Nabil Shabshab - PRE
Who are the major shareholders of Inogen Inc?

Here are the top five shareholders of Inogen Inc based on the size of their shareholding:

Brown Capital Management, LLC Investment Advisor
Percentage owned: 17.86% (3.97m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 12.71% (2.83m shares)
Novo Holdings A/S Venture Capital
Percentage owned: 12.4% (2.76m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 10.11% (2.25m shares)
Brown Capital Management Small Company Fund Mutual Fund
Percentage owned: 8.58% (1.91m shares)
Similar to INGN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.